Prosecution Insights
Last updated: May 29, 2026

Examiner: GANESAN, SUBA

Tech Center 3700 • Art Units: 3774

This examiner grants 74% of resolved cases

Performance Statistics

73.7%
Allow Rate
+3.7% vs TC avg
697
Total Applications
+14.0%
Interview Lift
1220
Avg Prosecution Days
Based on 668 resolved cases, 2023–2026

Rejection Statute Breakdown

0.1%
§101 Eligibility
10.4%
§102 Novelty
85.4%
§103 Obviousness
2.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19334242 METHODS FOR DEPLOYMENT OF AN IMPLANT Non-Final OA Zenflow, Inc.
18375390 SYSTEMS AND METHODS FOR ALTERING THE SHAPE OF NASAL TISSUES Final Rejection Mayo Foundation for Medical Education and Research
18448726 PROSTHETIC VALVES Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18308525 APPARATUS AND METHODS FOR REDUCING PARAVALVULAR LEAKAGE Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18181521 COMPRESSIBLE SHUNT IMPLANT Non-Final OA EDWARDS LIFESCIENCES CORPORATION
17826029 PROSTHETIC HEART VALVES WITH COMMISSURE POST PROTRUSIONS FOR COMMISSURE ASSEMBLY POSITION LOCKING Non-Final OA Edwards Lifesciences Corporation
18280085 JOINT DEVICE Non-Final OA HONDA MOTOR CO., LTD.
17849565 BIOHYBRID HEART VALVE REPLACEMENT Non-Final OA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18062491 Stent And Stent Connection Interface Final Rejection MicroVention, Inc.
17977406 RINGLESS WEB FOR REPAIR OF HEART VALVES Non-Final OA NeoChord, Inc.
18115502 DEVICES AND METHODS FOR DELIVERY OF VALVE PROSTHESES Non-Final OA JC Medical, Inc.
18540305 TRANSCATHETER ATRIO-VENTRICULAR VALVE PROSTHESIS Non-Final OA HIGHLIFE SAS
18400252 PROSTHETIC HEART VALVES Non-Final OA CorMatrix Cardiovascular, Inc.
18035509 TRANSCATHETER DEVICE FOR TREATING TRICUSPID VALVE REGURGITATION Non-Final OA TAU MEDICAL INC.
18519930 Medical Device using Bioabsorbable Material Non-Final OA Xeltis, B.V
18277215 SYSTEMS, METHODS, AND DEVICES FOR TREATING A DISEASED OR OTHERWISE DAMAGED TRICUSPID VALVE Non-Final OA Innoventric Ltd.
17505287 STENT FOR THE POSITIONING AND ANCHORING OF A VALVULAR PROSTHESIS IN AN IMPLANTATION SITE IN THE HEART OF A PATIENT Non-Final OA JenaValve Technology, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month